Cargando…

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)

BACKGROUND: In August of 2006, the Advisory Committee on Immunization Practices (ACIP) recommended RotaTeq for routine vaccination of US infants. The hypothesis tested in the present study is that rotavirus vaccines are associated with an increased risk of intussusception adverse events (AEs) charac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geier, David A., King, Paul G., Sykes, Lisa K., Geier, Mark R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2012
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560585/ https://www.ncbi.nlm.nih.gov/pubmed/22293889 http://dx.doi.org/10.12659/MSM.882470

Ejemplares similares

G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States
por: Roy, Sunando, et al.
Publicado: (2015)

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)

Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports
por: Riad, Abanoub, et al.
Publicado: (2022)

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study
por: Vesikari, Timo, et al.
Publicado: (2010)

Assessing bias in administrative database studies of RotaTeq vaccine completion due to exclusion of subjects with incomplete follow-up
por: Lanes, Stephan, et al.
Publicado: (2015)

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland
por: Hemming, Maria, et al.
Publicado: (2013)

Corrigendum: Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples
por: Gautam, Rashi, et al.
Publicado: (2014)

Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®
por: Hartwig, Susanne, et al.
Publicado: (2014)

Ontology-based time information representation of vaccine adverse events in VAERS for temporal analysis
por: Tao, Cui, et al.
Publicado: (2012)

Adverse event detection by integrating twitter data and VAERS
por: Wang, Junxiang, et al.
Publicado: (2018)

One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples
por: Gautam, Rashi, et al.
Publicado: (2016)

Identification of sex-associated network patterns in Vaccine-Adverse Event Association Network in VAERS
por: Zhang, Yuji, et al.
Publicado: (2015)

A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
por: Geier, David A., et al.
Publicado: (2014)

Linked vaccine adverse event data from VAERS for biomedical data analysis and longitudinal studies
por: Tao, Cui, et al.
Publicado: (2014)

Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports
por: Guo, Wenxin, et al.
Publicado: (2022)

Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics’ impact
por: Almadani, Ohoud A., et al.
Publicado: (2022)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2022)

WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
por: Rose, Jessica, et al.
Publicado: (2021)

Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains
por: Alfajaro, Mia Madel, et al.
Publicado: (2019)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Zhang, Bing, et al.
Publicado: (2022)

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
por: Aranaz Andrés, Jesus Maria, et al.
Publicado: (2017)

EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports
por: Alqahtani, Z, et al.
Publicado: (2022)

Under-reporting of maternal and perinatal adverse events in New Zealand
por: Farquhar, Cynthia, et al.
Publicado: (2015)

Adverse Childhood Events and Health Biomarkers: A Systematic Review
por: Soares, Sara, et al.
Publicado: (2021)

Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data
por: Tao, Cui, et al.
Publicado: (2015)

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023)

Adverse events following immunization of COVID-19 vaccine among children aged 6–11 years
por: Puspitarani, Fitriana, et al.
Publicado: (2022)

A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
por: Cappelletti-Montano, Beniamino, et al.
Publicado: (2023)

Assessing the effect of adverse economic events on severity of hunger among food pantry clients
por: Bangham, Candice, et al.
Publicado: (2023)

Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study
por: Alkhalifah, Joud Mohammed, et al.
Publicado: (2023)

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)

Capturing a Comprehensive Picture of Biological Events From Adverse Outcome Pathways in the Drug Exposome
por: Wu, Qier, et al.
Publicado: (2021)

Early recognition of risk of critical adverse events based on deep neural decision gradient boosting
por: Chen, Yu-wen, et al.
Publicado: (2023)

Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations
por: Sagreiya, Hersh, et al.
Publicado: (2017)

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990–2010
por: Goldman, GS, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_egumi4ffqi6vjjk3fl6gb7ug2g